Distinguished Colleagues and Guests
Outstanding level our country has reached in Inherited Bleeding Disorders has been achieved by T.C.Ministry of Health and Social Security Institution as well as with committed efforts of The Hemophilia Society of Turkey and Hemophilia Federation.
Hemophilia community always remembers the efforts that allow them to be healthy and increase their quality of life with appreciation and gratitude. To carry the success in hemophilia and other bleeding disorders field further, Hemophilia Federation and The Hemophilia Society of Turkey will jointly organize the 17th International Turkey Hemophilia Congress in December 18 - 20, 2020 on online.
We await your participation to “2020 – We are Nearly to Arrive” where we will collectively evaluate the developments, current state, and targets; and we wish you health and wellbeing.
Louis ALEDORT
Bülent ANTMEN
Can BALKAN
Hans Hermann BRACKMANN
Ergül BERBER
Mirella CALCINAI
Horacio CAVIGLIA
Pratima CHOWDARY
Carmen ESCURIOLA
Tunç FIŞGIN
Kaan KAVAKLI
Alphan KÜPESİZ
Stefan LETHAGEN
Johnny MAHLANGU
Alex MEHUYS
Sylvia Von MACKENSEN
John PASI
Mathew PRASAD
Cüneyt TÜRKMEN
Bülent ZÜLFİKAR
Louis Aledort
Hans-Hermann Brackmann
Mirella Calcinai
Horacio Caviglia
Pratima Chowdary
Alison Dougall
Carmen Escuriola
Stefan Lethagen
Sylvia Von Mackensen
Johnny Mahlangu
Prasad Mathew
Alex Mehuys
Johannes Oldenburg
John Pasi
| MEDICAL HALL | |
| 17:50 - 18:00 | OPENING |
| 18:00 - 18:45 |
PANEL 1
Starting Point
Destination Q&A |
| 18:45 - 19:15 |
CONFERENCE 1 Speaker: Ekrem Ünal |
| 19:15 - 20:00 |
PANEL 2
Long-Term Outcomes at a Glance
More Than Factor Replacement Breaking News Q&A |
| 20:00 - 21:15 |
IN THE MEMORY OF AXEL SEUSER
Hemophilic Arthropathy; Pathophysiology and Preventive Approaches
Musculo - Skeletal Ultrasonography
Arthroplasty Applications in Hemophilic Arthropathy
Radioisotope Synovectomy Q&A |
| MEDICAL HALL | |
| 11:00 - 11:30 |
CONFERENCE 2 Speaker: Sylvia Von Mackensen |
| 11:30 - 12:25 |
PANEL 4
Plasminogen Deficiency and Treatment Options
Treatment of Ligneous Conjunctivitis in patients with Type I Plasminogen deficiency: results of a Phase II/III Clinical Trial
Factor X Deficiency and Treatment Options Q&A |
| 12:25 - 12:35 | ACTION BREAK - 1 |
| 12:35 - 13:35 |
ORAL PRESENTATIONS - 1
SS-001
Plasminogen eye drops for the treatment of ligneous conjunctivitis and the prevention of recurrences in patients with type 1 plasminogen deficiency: results from the phase II/III clinical trial
SS-003 Circumcision in Haemophilia with Inhibitors During Emicizumab Prophylaxis
SS-004 Clinical problems and surgical interventions in inherited factor VII deficiency SS-005 Is Dental Implant Treatment Safe in Hemophilia Patients?
SS-006
Five years of experience for treatment regimens of PUP patients in Hemophilia-A: experience from Ege Hemophilia Center Q&A |
| 13:35 - 14:20 |
INDUSTRY SYMPOSIUM FIX PHARMACOKINETICS & CORRECT DOSING Speakers: İlgen Şaşmaz, Bülent Antmen, Can Balkan Q&A |
| BREAK | |
| 16:30 - 17:00 |
PANEL 5 Speakers: Gül Talu, Yöntem Yaman Q&A |
| 17:00 - 17:45 |
INDUSTRY SYMPOSIUM LONG TERM SAFETY AND EFFICACY WITH TUROCTOCOG ALFA IN THE LIGHT OF CLINICAL DATA AND TURKISH EXPERIENCE Speaker: Pratima Chowdary, Saadet Akarsu, Emine Türkkan Q&A |
| 17:45 - 18:15 |
CONFERENCE 3 Speaker: John Pasi |
| 18:15 - 18:30 | ACTION BREAK - 2 |
| 18:30 - 19:15 |
INDUSTRY SYMPOSIUM
Factor VIII Experience in Hemophilia A Treatment
FVIII Standard of Care in Hemophilia A Treatment
Hemophilia A and Bayer Q&A |
| 19:15 - 20:00 |
INDUSTRY SYMPOSIUM TAKE CONTROL WITH A PROVEN EFFICACY AND SAFETY PROFILE BUILT OVER 45 YEARS OF REAL WORLD EXPERIENCE IN HEMOPHILIA A WITH INHIBITORS
Feiba Efficacy and Safety Overview with Experience Sharing
Feiba Experience Worldwide with Meeting the Needs for 45 Years Q&A |
| 20:00 - 20:15 | ACTION BREAK - 3 |
| 20:15 - 20:45 |
CONFERENCE 4 Speaker: Fahri Ovalı |
| 20:45 - 21:30 |
NAVIGATING TOWARDS A MILESTONE IN HEMOPHILIA A TREATMENT: GERMANY & SOUTH AFRİCA
Hemlibra Experience with Quick Questions & Real World Cases Q&A |
| GÜNDÜZ GEDİKOĞLU HALL | |
| 15:30 - 16:30 |
PANEL 1
Health Practition Legislation
Rights of Handicapped People and Reporting
Clinical Research and Volunteering Q&A |
| 16:30 - 17:00 |
CONFERENCE 1 |
| 17:00 - 18:00 |
PANEL 2
Treatment of Gynecological Bleeding
Pregnancy and Childbirth
IVF and Genetic Counselling
Family Perspective and Expectations Q&A |
| 18:00 - 18:15 | ACTION BREAK - 1 |
| 18:15 - 19:15 |
PANEL 3
Pain Management
Physical Therapy and Rehabilitation
Radiological Evaluation
Physiotherapy and Clinical Scoring Q&A |
| 19:15 - 20:15 |
PANEL 4
Hemophilia Psychology
Family Psychology
Nutrition for Bleeding Problems Q&A |
| 20:15 - 20:30 | ACTION BREAK - 2 |
| 20:30 - 21:30 |
PANEL 5
New Diagnosis
School and Education Life
Family Life
Business Life Q&A |
| 21:30 - 22:00 |
CONFERENCE 2 Chairmen: Bülent Zülfikar, Kaan Kavaklı Speaker: Louis Aledort |
| SYMPOSIUM HALL | |
| DENTISTRY SYMPOSIUM - 1 | |
| 10:00 - 10:20 |
OPENING SPEECH |
|
SESSION 1 |
|
| 10:20 - 10:50 |
Protective Approach in Pediatric Patients and Quality of Life Cem Doğan |
| 10:50 - 11:20 |
Protection from Tooth Decay Safa Tuncer |
| 11:20 - 11:50 |
Protection from Periodental Diseases Ali Çekici |
| 11:50 - 12:00 | Q&A |
| NURSING SYMPOSIUM HEMOPHILIA - 1 | |
| 12:00 - 12:15 |
OPENING SPEECH |
|
SESSION 1 Chairmen: Yusuf Büyükpınarbaşılı, Selmin Şenol, Hanife Özcan, Hülya Bingöl Dalkılıç |
|
| 12:15 - 12:40 |
Hemophilia Diagnosis and Symptoms Bülent Zülfikar |
| 12:40 - 13:05 |
Treatment Options in Hemophilia Alphan Küpesiz |
| 13:05 - 13:30 |
Laboratory Analysis, Sample Collection and Interpretation Erol Erduran |
| 13:30 - 13:45 | Q&A |
| 13:45 - 13:55 | ACTION BREAK - 1 |
| 13:55 - 14:15 |
Inhibitor Problems and Solutions Başak Koç Şenol , Emine Gül Kuzucu |
| 14:15 - 14:30 |
Past And Present Hemophilia Treatment and Nursing Management Selmin Şenol |
| 14:30 - 14:45 |
Step by Step Factor Infusion Hanife Özcan |
| 14:45 - 15:00 | Q&A |
| BREAK | |
|
DENTISTRY SYMPOSIUM - 2 |
|
|
SESSION 2 WFH GUIDELINES AND COVID 19 IN BLEEDING DISEASES Chairman: Gülsüm Ak, Yusuf Büyükpınarbaşılı |
|
| 15:00 - 15:40 |
WFH Guidelines for Dental Problems in Bleeding Disorders  Alison Dougall |
| 15:40-16:20 |
The Effect of Covid 19 Disease on Dental Practices Figen Çizmeci Şenel |
| 16:20 - 16:30 | Q&A |
|
SESSION 3 |
|
| 16:30-16:50 |
Treatment Approaches to be Followed During Oral Surgical Procedures on Hemophilia A Patients Nur Mollaoğlu |
| 16:50 - 17:10 |
Treatment Approaches to be Followed During Oral Surgical Procedures on Hemophilia B Patients Sibel Elif Gültekin |
| 17:10 - 17:30 |
Implant Surgery in Hemophilic Patients Gülsüm Ak |
| 17:30 - 18:00 | Q&A |
| 18:00 - 19:00 |
ORAL PRESENTATIONS
SS-013 Evaluation of Temporomandibular Joint Health in Hemophilic
SS-014 Dental Procedures in a Hemophiliac with Inhibitor during Emicizumab Prophylaxis
SS-015 Current Approaches of Maxillofacial Surgery in Patients with Coagulation Disorders: Together with Case Presentations
SS-016 Prevalence of oral diseases in patients with inherited bleeding disorders Q&A |
| MEDICAL HALL | |
| 10:45 - 12:00 |
PANEL 6
Management at Medical P roblems due to Aging
Acquired Factors Deficiencies
Future Vision of Hemophilia
Approach to Adult Hemophilia Centers Q&A |
| 12:00 - 12:30 |
PANEL 7
Expert Evaluation
Application of New Techniques Q&A |
| 12:30 - 13:00 |
PANEL 8 Speakers: Haluk Zülfikar, Mehmet Can Uğur Q&A |
| 13:00 - 13:10 | ACTION BREAK - 1 |
| 13:10 - 14:10 |
ORAL PRESENTATIONS - 2 SS-007 Our Patients with Hereditary FXI Deficiency and Phenotype-Genotype Relationship
SS-008 Patient and Relative Perspective on New Treatment Options in Hemophilia
SS-009 Patients Monitored with a Diagnosis of Factor VII Deficiency: A Single Center Experience
SS-010 One of the Important Facts Faced by Hemophilia Patients; Cancer SS-011 Harmony in Marriage And Sexual Life in Women in Families with Hemophilia and Women in Families Without Hemophilia
SS-012 Comparison of Psychological Resilience, Psychiatric Symptoms and Sexual Satisfaction of Hemophilia Patients and Healthy Individuals Q&A |
| BREAK | |
| 17:00 - 17:45 |
INDUSTRY SYMPOSIUM WHY DO WE STILL NEED FVIII IN THE CURRENT ERA?
FVIII Usage Results in PUPs
Role of FVIII in Hemostasis and Beyond Q&A |
| 17:45 - 18:30 |
REFERENCE IN HEMOPHİLİA – INTERACTİVE PATIENT CASE SİMULATİON Speaker: Adalet Meral Güneş Q&A |
| 18:30 - 18:40 | ACTION BREAK - 2 |
| 18:40 - 19:25 |
INDUSTRY SYMPOSIUM
VON WILLEBRAND DISEASE: RECENT NEWS & PRACTICES Speaker: Carmen Escuriola , Sinan Akbayram Q&A |
| 19:25 - 20:25 |
PANEL 9 Şuayip Birinci (T.C Sağlık Bakan Yardımcısı) Q&A |
| 20:25 - 20:40 | Award Cerenomy and Closing |
| SYMPOSIUM HALL | |
| HEREDITARY BLEEDING DISORDERS MUSCOLOSKELETAL HEALTH SYMPOSIUM - 1 | |
| 11:00 - 11:15 |
OPENING SPEECH Kazım Çapacı, Necati Tat, Canan Atay |
|
SESSION 1 Chairmen: Kazım Çapacı,Semih Aydoğdu |
|
| 11:15 - 11:40 |
Introduction to Hemostasis Gül Nihal Özdemir |
| 11:40 - 12:05 |
Diagnosis and Treatment on Hemophilia Yıldız Yıldırmak |
| 12:05 - 12:30 |
Importance and Problems of Muscle and Joint Health Gökhan Polat |
| 12:30 - 12:45 | Q&A |
| 12:45 - 12:55 | ACTION BREAK - 1 |
| 12:55 - 13:20 |
Orthopedic Surgery in Hemophilia 1 Semih Aydoğdu |
| 13:20 - 13:45 |
Orthopedic Surgery in Hemophilia 2 Önder Kılıçoğlu |
| 13:45 - 14:00 | Q&A |
| NURSING SYMPOSIUM HEMOPHILIA - 2 | |
|
SESSION 2 Chairmen: Selmin Şenol, Fikret Bezgal |
|
| 14:00- 14:25 |
First 0 - 18 Years in Hemophilia (Selfcare, Vaccination family dynamics, School Activities) Hayriye Başer |
| 14:25 - 14:50 |
Importance at Hemophilia and Sport , Excercise Bülent Bayraktar |
| 14:50 – 15:15 |
Hemophilia as a Genetic Disease and Family Tree Structure Ergül Berber |
| 15:15 - 15:30 | Q&A |
| 15:30 - 15:40 | ACTION BREAK - 2 |
| 15:40 - 16:05 |
Bleeding Women and Nursing Approach on the Basis of VWB EmineTürkkan, Hülya Bingöl Dalkılıç |
| 16:05 - 16:30 |
Clinical Trials and Regulations Göksel Leblebisatan |
| 16:30 - 16:45 | Q&A |
| 16:45 - 17:00 |
Questions and Evoluation Closing |
| HEREDITARY BLEEDING DISORDERS MUSCOLOSKELETAL HEALTH SYMPOSIUM - 2 | |
|
SESSION 2 Chairmen: Kazım Çapacı, Gökhan Polat |
|
| 17:00 - 17:20 |
Physiotherapy on Hemophilia Kazım Çapacı, Ece Çınar |
| 17:20 - 17:50 |
Excercise on Hemophilia Kazım Çapacı, Ece Çınar |
| 17:50 - 18:15 |
Examination of Arthrosis and Clinical Scoring Necati Tat |
| 18:15 - 18:45 |
Rehabilitation on Hemophilia Canan Atay |
| 18:45 - 18:55 | Q&A |
| 18:55 - 19:00 | Closing and Remarks |
| Register type | Prices |
| Doctor | 3.750 TL |
| Assistant - Student | 3.000 TL |
| Nurse | 3.000 TL |
| Exhibitor | 3.750 TL |
| Patients / Patient Relatives * Patients and their relatives will be able to attend the relevant sessions free of charge. For your registration requests, we ask you to contact the Association and Federation secretariats. |
Free |
Services Included in Registration Fees,
| Account Name: | TOPKON TURİSTİK HİZ. YAT. İNŞ. VE TİC. LTD.ŞTİ. |
| The Bank Name: | İŞ BANKASI |
| Branch Code: | 1394 |
| Swift Code: | ISBKTRIS |
| TL IBAN Number: | TR26 0006 4000 0011 3940 0080 09 |
Abstract Summary Rules
Feedback
Information on whether the paper summary has been accepted will be sent with e-mail.
You may contact with Topkon Congress Services (hemofili2020@topkon.com)
The papers awarded by the selection committee at the end of the congress;
Oral Presentations;
5.000 TL for the first
3.000 TL for the second
2,000 TL for the third
Poster Presentation
1,500 TL for the first
CONGRESS DATES
December 18 – 20, 2020
CERTIFICATE OF PARTICIPATION
Participation documents for all scientific program participants will be sent as PDF after the congress.
INVITATION LETTER / PERMISSION
Invitation letters that will be requested to be given to the institutions for participation in the congress will be sent to the participants who want to participate through the congress secretariat. Such invitation letters can only be used for permission purposes. Registration and accommodation fees of the guests who have invitation letters belong to them.
Dear Colleagues,
Due to COVID-19 pandemic spreading all around the world, new reguations and precautions has been taking by our Ministry.
On Behalf of Hemophilia Federation and The Hemophilia Society of Turkey, 17th International Turkey Hemophilia Congress which would be held in Maritim Pine Beach Hotel, Antalya on April 16-19, 2020 has decided to postpone December 10-13, 2020 due to COVID-19 Pandemic as a result of desicions taken by Ministry of Health of Turkey. The Congress will be held in Maritim Pine Beach Otel, Antalya same as before.
We await your participation to “2020 – We are Nearly to Arrive” where we will collectively evaluate the developments, current state, and targets; and we wish you health and wellbeing.
18th International Hemophilia Congress of Turkey will be held in Susesi Hotel, Antalya, Turkey on May 27-30, 2021.
Best regards.
Organization Committee of Hemophilia Congress.
INDUSTRY SYMPOSIUM